WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Optimizing Fall-risk Prediction in Older Adults With Cancer

Completed

Conditions: Cancer

Interventions: Other: Baseline Participant Assessment
Other: Baseline Healthcare Provider Assessment
Other: Follow-up Participant Assessment
Other: Follow-up Healthcare Provider Assessment
Other: End-of-study Participant Assessment
Other: End-of-study Healthcare Provider Assessment

First Posted Date: 2016-09-23

Last Posted Date: 2020-10-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 227

Registration Number: NCT02912273

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Movement Pattern Training in People With Intra-articular, Prearthritic Hip Disorders

Not Applicable

Completed

Conditions: Prearthritic Hip Disease
Chronic Hip Joint Pain

Interventions: Other: Rehabilitation

First Posted Date: 2016-09-23

Last Posted Date: 2023-03-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 46

Registration Number: NCT02913222

Locations: 🇺🇸
Program in Physical Therapy, Washington University, Saint Louis, Missouri, United States
🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II

Phase 2

Completed

Conditions: Respiratory Syncytial Virus, Bronchiolitis

Interventions: Drug: Placebo
Drug: Oral azithromycin

First Posted Date: 2016-09-22

Last Posted Date: 2022-06-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 200

Registration Number: NCT02911935

Locations: 🇺🇸
Department of Pediatrics, Washington University School of Medicine; and St. Louis Children's Hospital, Saint Louis, Missouri, United States

Relieving Chronic Itch: Oral Medication

Phase 2

Withdrawn

Conditions: Pruritis

Interventions: Drug: INCB039110

First Posted Date: 2016-09-21

Last Posted Date: 2019-05-13

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02909569

Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer
Cancer of Breast
Breast Carcinoma

Interventions: Drug: Palbociclib
Drug: Letrozole
Biological: Trastuzumab
Drug: Goserelin
Procedure: Breast surgery
Procedure: Research tumor biopsy
Procedure: Research bone marrow (OPTIONAL)
Procedure: Research blood sample
Genetic: Research blood for germline DNA
Procedure: Blood for detection of circulating tumor cells

First Posted Date: 2016-09-20

Last Posted Date: 2021-09-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 26

Registration Number: NCT02907918

Locations: 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States
🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Using Social Norms to Encourage People to Exercise More

Not Applicable

Conditions: Physical Activity

Interventions: Behavioral: Email invitation
Behavioral: Social norm
Behavioral: Extrinsic, reward motive
Behavioral: Intrinsic, health motive

First Posted Date: 2016-09-20

Last Posted Date: 2016-09-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15000

Registration Number: NCT02907164

Locations: 🇺🇸
Hengchen Dai, St. Louis, Missouri, United States

Using Self-Motivating Messages to Encourage People to Exercise More

Not Applicable

Completed

Conditions: Physical Activity

Interventions: Behavioral: Drafting Motivational Messages
Behavioral: Control Reminders
Behavioral: Treatment Reminders

First Posted Date: 2016-09-16

Last Posted Date: 2017-05-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 324

Registration Number: NCT02903849

Locations: 🇺🇸
Hengchen Dai, Saint Louis, Missouri, United States

CSF Pharmacokinetics of Ondansetron

Not Applicable

Completed

Conditions: Pain

Interventions: Drug: Ondansetron

First Posted Date: 2016-09-15

Last Posted Date: 2019-12-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 19

Registration Number: NCT02901054

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis

Not Applicable

Completed

Conditions: Lymphatic Filariasis

Interventions: Drug: 3 drug dose - IDA
Drug: 2 drug dose - DA

First Posted Date: 2016-09-14

Last Posted Date: 2020-12-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 23789

Registration Number: NCT02899936

Locations: 🇭🇹
Ministere de la Sante Publique et de la Population, Port-au-Prince, Haiti
🇮🇳
Vector Control Research Centre, Puducherry, India
🇮🇩
Universitas Indonesia, Jakarta, Indonesia

and more 1 locations

Remifentanil in Adults With OSA

Early Phase 1

Completed

Conditions: Apnea, Sleep

Interventions: Drug: Targeted infusion of remifentanil

First Posted Date: 2016-09-13

Last Posted Date: 2018-10-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 77

Registration Number: NCT02898792

Locations: 🇺🇸
Washington University St Louis School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy